Inquiries About Biomarkers of Acute Liver Failure in Patients Who Underwent Living Donor Liver Transplantation Using a Protein Chip Array

Yo ichi Yamashita, Tomoharu Yoshizumi, Toru Ikegami, Hideaki Uchiyama, Eiji Tsujita, shinji itoh, Norifumi Harimoto, Yuji Soejima, Akinobu Taketomi, Hideo Baba, Yoshihiko Maehara

Research output: Contribution to journalArticle

Abstract

The causative agent of hepatic encephalopathy (HE) has not been identified with certainty. The recovery of consciousness in patients with acute liver failure (ALF) who underwent liver transplantation (LT) is sometimes drastic ; therefore, we thought that the causative agents of HE would change markedly peri-operatively in these patients. We examined the biomarkers including new agents in the serum of patients using the ProteinChip® System 4000 (Ciphergen Biosystems, Yokohama, JAPAN). Sixteen samples were obtained from four patients with ALF who underwent living donor LT (LDLT) at four time points ; pre-operative, one post-operative day (1POD), 3POD, and 7POD. We used three chips made by the Biomek2000 robot. All duplicated samples were assayed and analyzed using the CiphergenExpressTM data manager. We divided the peri-operative changes in the intensity of identified peaks into seven patterns. The number of peaks whose intensity shows significant changes peri-operatively reached 755. Of course, it is difficult to determine each structure in all 755 peaks ; therefore, we should narrow down the candidates for causative agents of HE in further studies. Our own results suggest that many difficulties lie ahead in determining the causative agent of HE.

Original languageEnglish
Pages (from-to)131-135
Number of pages5
JournalFukuoka igaku zasshi = Hukuoka acta medica
Volume107
Issue number7
Publication statusPublished - Jul 1 2016

Fingerprint

Protein Array Analysis
Hepatic Encephalopathy
Acute Liver Failure
Living Donors
Liver Transplantation
Biomarkers
Consciousness
Serum

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Inquiries About Biomarkers of Acute Liver Failure in Patients Who Underwent Living Donor Liver Transplantation Using a Protein Chip Array. / Yamashita, Yo ichi; Yoshizumi, Tomoharu; Ikegami, Toru; Uchiyama, Hideaki; Tsujita, Eiji; itoh, shinji; Harimoto, Norifumi; Soejima, Yuji; Taketomi, Akinobu; Baba, Hideo; Maehara, Yoshihiko.

In: Fukuoka igaku zasshi = Hukuoka acta medica, Vol. 107, No. 7, 01.07.2016, p. 131-135.

Research output: Contribution to journalArticle

Yamashita, Yo ichi ; Yoshizumi, Tomoharu ; Ikegami, Toru ; Uchiyama, Hideaki ; Tsujita, Eiji ; itoh, shinji ; Harimoto, Norifumi ; Soejima, Yuji ; Taketomi, Akinobu ; Baba, Hideo ; Maehara, Yoshihiko. / Inquiries About Biomarkers of Acute Liver Failure in Patients Who Underwent Living Donor Liver Transplantation Using a Protein Chip Array. In: Fukuoka igaku zasshi = Hukuoka acta medica. 2016 ; Vol. 107, No. 7. pp. 131-135.
@article{d5661bd365df4678967bced2e79af36f,
title = "Inquiries About Biomarkers of Acute Liver Failure in Patients Who Underwent Living Donor Liver Transplantation Using a Protein Chip Array",
abstract = "The causative agent of hepatic encephalopathy (HE) has not been identified with certainty. The recovery of consciousness in patients with acute liver failure (ALF) who underwent liver transplantation (LT) is sometimes drastic ; therefore, we thought that the causative agents of HE would change markedly peri-operatively in these patients. We examined the biomarkers including new agents in the serum of patients using the ProteinChip{\circledR} System 4000 (Ciphergen Biosystems, Yokohama, JAPAN). Sixteen samples were obtained from four patients with ALF who underwent living donor LT (LDLT) at four time points ; pre-operative, one post-operative day (1POD), 3POD, and 7POD. We used three chips made by the Biomek2000 robot. All duplicated samples were assayed and analyzed using the CiphergenExpressTM data manager. We divided the peri-operative changes in the intensity of identified peaks into seven patterns. The number of peaks whose intensity shows significant changes peri-operatively reached 755. Of course, it is difficult to determine each structure in all 755 peaks ; therefore, we should narrow down the candidates for causative agents of HE in further studies. Our own results suggest that many difficulties lie ahead in determining the causative agent of HE.",
author = "Yamashita, {Yo ichi} and Tomoharu Yoshizumi and Toru Ikegami and Hideaki Uchiyama and Eiji Tsujita and shinji itoh and Norifumi Harimoto and Yuji Soejima and Akinobu Taketomi and Hideo Baba and Yoshihiko Maehara",
year = "2016",
month = "7",
day = "1",
language = "English",
volume = "107",
pages = "131--135",
journal = "Fukuoka Acta Medica",
issn = "0016-254X",
publisher = "福岡医学会",
number = "7",

}

TY - JOUR

T1 - Inquiries About Biomarkers of Acute Liver Failure in Patients Who Underwent Living Donor Liver Transplantation Using a Protein Chip Array

AU - Yamashita, Yo ichi

AU - Yoshizumi, Tomoharu

AU - Ikegami, Toru

AU - Uchiyama, Hideaki

AU - Tsujita, Eiji

AU - itoh, shinji

AU - Harimoto, Norifumi

AU - Soejima, Yuji

AU - Taketomi, Akinobu

AU - Baba, Hideo

AU - Maehara, Yoshihiko

PY - 2016/7/1

Y1 - 2016/7/1

N2 - The causative agent of hepatic encephalopathy (HE) has not been identified with certainty. The recovery of consciousness in patients with acute liver failure (ALF) who underwent liver transplantation (LT) is sometimes drastic ; therefore, we thought that the causative agents of HE would change markedly peri-operatively in these patients. We examined the biomarkers including new agents in the serum of patients using the ProteinChip® System 4000 (Ciphergen Biosystems, Yokohama, JAPAN). Sixteen samples were obtained from four patients with ALF who underwent living donor LT (LDLT) at four time points ; pre-operative, one post-operative day (1POD), 3POD, and 7POD. We used three chips made by the Biomek2000 robot. All duplicated samples were assayed and analyzed using the CiphergenExpressTM data manager. We divided the peri-operative changes in the intensity of identified peaks into seven patterns. The number of peaks whose intensity shows significant changes peri-operatively reached 755. Of course, it is difficult to determine each structure in all 755 peaks ; therefore, we should narrow down the candidates for causative agents of HE in further studies. Our own results suggest that many difficulties lie ahead in determining the causative agent of HE.

AB - The causative agent of hepatic encephalopathy (HE) has not been identified with certainty. The recovery of consciousness in patients with acute liver failure (ALF) who underwent liver transplantation (LT) is sometimes drastic ; therefore, we thought that the causative agents of HE would change markedly peri-operatively in these patients. We examined the biomarkers including new agents in the serum of patients using the ProteinChip® System 4000 (Ciphergen Biosystems, Yokohama, JAPAN). Sixteen samples were obtained from four patients with ALF who underwent living donor LT (LDLT) at four time points ; pre-operative, one post-operative day (1POD), 3POD, and 7POD. We used three chips made by the Biomek2000 robot. All duplicated samples were assayed and analyzed using the CiphergenExpressTM data manager. We divided the peri-operative changes in the intensity of identified peaks into seven patterns. The number of peaks whose intensity shows significant changes peri-operatively reached 755. Of course, it is difficult to determine each structure in all 755 peaks ; therefore, we should narrow down the candidates for causative agents of HE in further studies. Our own results suggest that many difficulties lie ahead in determining the causative agent of HE.

UR - http://www.scopus.com/inward/record.url?scp=85041768193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041768193&partnerID=8YFLogxK

M3 - Article

C2 - 29226663

AN - SCOPUS:85041768193

VL - 107

SP - 131

EP - 135

JO - Fukuoka Acta Medica

JF - Fukuoka Acta Medica

SN - 0016-254X

IS - 7

ER -